Jeff Szer
@marrow
Followers
2K
Following
4K
Media
1K
Statuses
15K
Clinical Haematologist, marrow transplanter. expertise in Gaucher Disease and PNH. Past President of WMDA and WBMT. Editor-in-Chief Internal Medicine Journal.
Melbourne, Australia
Joined June 2007
IMJ October 2025 #FreeAccess Original Article: Post-transplant lymphoproliferative disorder in liver transplant https://t.co/HRRW3ibbsh
@TheRACP @WileyHealth @drobeirne
0
2
2
IMJ October 2025 #OpenAccess Original Article: Point-of-care ultrasound in internal medicine https://t.co/yuvkptaEOY
@TheRACP @WileyHealth
0
2
2
IMJ October 2025 #OpenAccess Original Article: Neurological manifestations of chronic graft versus host disease https://t.co/ICq8ff3QAS
@TheRACP @WileyHealth
0
2
2
IMJ October 2025 #FreeAccess Original Article: Endoscopy for oesophageal food bolus impactions https://t.co/hlttc6gUg4
@TheRACP @WileyHealth @Russeldm
0
2
2
IMJ October 2025 #FreeAccess Editorial: A, B, C or D? Goals of Care: a need for a national structural framework. https://t.co/87Dy8Oeopv
@TheRACP @WileyHealth
0
2
1
IMJ October 2025 #OpenAccess Editor's Choice (Clinical Perspective): Hyperhidrosis: don’t sweat it https://t.co/C6cDJTHNrJ
@TheRACP @WileyHealth
0
1
1
IMJ October (Vol 55, Iss 10) is now online https://t.co/s8z8gVmoCK
@PaulBridgmanMD @TheRACP @WileyHealth @AndrewMallett8 @DanSteinfort @Russeldm @ianjohnwoolley2 @drobeirne @inglisjosh @les_sheffield @pkomesar @Badves @szetinglee1 @marrow
0
3
5
My take from #IMS25: The myeloma landscape is evolving at remarkable speed. Early intervention is becoming reality, while patient-centric care, balancing transplant vs. non-transplant approaches, frailty assessment, tailored dosing and shorter duration of therapy guided by MRD,
4
25
87
IMJ September 2025 #FreeAccess Original Article: Is incidence and burden of cancer increasing among young individuals? https://t.co/CHN1EWuDTG
@TheRACP @WileyHealth
0
1
2
IMJ September 2025 #FreeAccess Original Article: In-hospital cardiac arrest https://t.co/4woPlrYOwx
@TheRACP @WileyHealth @PaulBridgmanMD
0
2
3
IMJ September 2025 #FreeAccess Review: Replacement therapy in congenital adrenal hyperplasia https://t.co/piVS5ugG13
@TheRACP @WileyHealth
0
1
2
IMJ September 2025 #OpenAccess Editor's Choice (Clinical Perspective): Medicinal cannabis: is current use clinically justified? https://t.co/AjM3omg9UY
@TheRACP @WileyHealth @YvonneBonomo
0
2
3
IMJ September 2025 #FreeAccess Editorial: Addressing medical instability from eating disorders – an urgent call to action https://t.co/lF3Vhrf4lS
@TheRACP @WileyHealth
0
2
3
IMJ September (Volume 55, Issue 9) is now online https://t.co/bsbWSgWK9m
@PaulBridgmanMD @TheRACP @WileyHealth @AndrewMallett8 @DanSteinfort @Russeldm @ianjohnwoolley2 @drobeirne @inglisjosh @les_sheffield @pkomesar @Badves @szetinglee1 @marrow
0
2
4
IMJ August 2025 #OpenAccess Viewpoint: Proposing core competencies for physicians in using AI https://t.co/tpcSEIQFoN
@TheRACP @WileyHealth
0
2
3
IMJ August 2025 #OpenAccess Original Article: Hyperuricaemia in Type 1 Gaucher disease https://t.co/2m9smZ7M6R
@TheRACP @WileyHealth @marrow
0
1
2
IMJ August 2025 #OpenAccess Original Article: The economic burden of sickle cell disease https://t.co/l8lUG5PFfP
@TheRACP @WileyHealth
0
1
2
IMJ August 2025 #OpenAccess Review: First-line treatment of osteoporosis with osteoanabolic therapy https://t.co/aWzJ5XxqSs
@TheRACP @WileyHealth
1
3
3
IMJ August 2025 #OpenAccess Clinical Perspective: Melanoma update – is a cure now in sight ? https://t.co/snpir43s9Y
@TheRACP @WileyHealth
0
3
3
IMJ August 2025 #FreeAccess Editorial: A new chapter for the journal https://t.co/EAh282EDao
@TheRACP @WileyHealth @PaulBridgmanMD
0
2
4